The role of coagulation and inflammation after angioplasty in patients with peripheral arterial disease

CardioVascular and Interventional Radiology

Volumn 29, Issue 4, 2006, Pages 530-535

  Wahlgren, C M ^a   Sten Linder, M ^a   Egberg, N ^a   Kalin, B ^a   Blohme L ^a   Swedenborg, J ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Angioplasty; Coagulation; CRP; Inflammation; PTA

Indexed keywords

C REACTIVE PROTEIN; D DIMER; FIBRINOGEN; PADGEM PROTEIN; PROTHROMBIN; THROMBOPLASTIN;

ADULT; AGED; ANGIOPLASTY; ARTERY DISEASE; ARTICLE; BIOCHEMISTRY; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; FEMORAL ARTERY; FOLLOW UP; HUMAN; ILIAC ARTERY; INFLAMMATION; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RESTENOSIS; STATISTICAL SIGNIFICANCE;

AGED; AGED, 80 AND OVER; ANGIOGRAPHY; ANGIOPLASTY; ARTERIAL OCCLUSIVE DISEASES; BLOOD COAGULATION; C-REACTIVE PROTEIN; FEMALE; FEMORAL ARTERY; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; ILIAC ARTERY; INFLAMMATION; INTERMITTENT CLAUDICATION; ISCHEMIA; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; POSTOPERATIVE COMPLICATIONS; RECURRENCE; TREATMENT OUTCOME;

EID: 33744775285     PISSN: 01741551     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00270-005-0159-0     Document Type: Article

References (35)

1. Pentecost MJ, Criqui MH, Dorros G, et al. (2003) Guidelines for peripheral percutaneous transluminal angioplasty of the abdominal aorta and lower extremity vessels. J Vasc Interv Radiol 14:S495-515
2. Schillinger M, Exner M, Mlekusch W, et al. (2002) Fibrinogen predicts restenosis after endovascular treatment of the iliac arteries. Thromb Haemost 87:959-965
3. Tschopl M, Tsakiris DA, Marbet GA, et al. (1997) Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty. Arterioscler Thromb Vasc Biol 17:3208-3214
4. Kovacevic T, Van Der Loo B, Amann-Vesti BR, et al. (2004) Plasma homocysteine and restenosis after femoropopliteal angioplasty. J Endovasc Ther 11:302-309
5. Colman R, Hirsh J, Marder V, et al. (2001). Hemostasis and thrombosis: Basic principles and clinical practice 4th edn. Philadelphia: Lippincott Williams & Wilkins, pp 743-752
6. Folsom AR (2001) Hemostatic risk factors for atherothrombotic disease: An epidemiologic view. Thromb Haemost 86:366-373
7. Lassila R, Peltonen S, Lepantalo M, et al. (1993) Severity of peripheral atherosclerosis is associated with fibrinogen and degradation of cross-linked fibrin. Arterioscler Thromb 13:1738-1742
8. Mizuno O, Ikeda U, Hojo Y, et al. (2001) Tissue factor expression in coronary circulation as a prognostic factor for late restenosis after coronary angioplasty. Cardiology 95:84-89
9. Hasenstab D, Lea H, Hart CE, et al. (2000) Tissue factor overexpression in rat arterial neointima models thrombosis and progression of advanced atherosclerosis. Circulation 101:2651-2657
10. Patterson C, Stouffer GA, Madamanchi N, et al. (2001) New tricks for old dogs: Nonthrombotic effects of thrombin in vessel wall biology. Circ Res 88:987-997
11. Davis C, Fischer J, Ley K, et al. (2003) The role of inflammation in vascular injury and repair. J Thromb Haemost 1:1699-1709
12. Ross R (1999) Atherosclerosis: an inflammatory disease. N Engl J Med 340:115-126
13. Esmon CT (2003) Inflammation and thrombosis. J Thromb Haemost 1:1343-1348
14. Ridker PM, Cushman M, Stampfer MJ, et al. (1998) Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 97:425-428
15. Schillinger M, Exner M, Mlekusch W, et al. (2002) Vascular inflammation and percutaneous transluminal angioplasty of the femoropopliteal artery: Association with restenosis. Radiology 225:21-26
16. Wang K, Zhou Z, Zhou X, et al. (2001) Prevention of intimal hyperplasia with recombinant soluble P-selectin glycoprotein ligand-immunoglobulin in the porcine coronary artery balloon injury model. J Am Coll Cardiol 38:577-582
17. Tanguay J, Geoffroy P, Sirois M, et al. (2004) Prevention of in-stent restenosis via reduction of thrombo-inflammatory reactions with recombinant P-selectin glycoprotein ligand-1. Thromb Haemost. 91:1186-1193
18. Rutherford RB, Baker JD, Ernst C, et al. (1997) Recommended standards for reports dealing with lower extremity ischemia: Revised version. J Vasc Surg 26:517-538
19. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. 1. Diagnosis and classification of diabetes mellitus: provisional report of a WHO consultation. Diabet Med 15:539-553
20. Whitworth JA (2003) 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 21:1983-1992
21. Harris E (1990) Special report. The Second International Anti-Cardiolipin Standardization Workshop, the Kingston Anti-Phospholipid Antibody Study (KAPS) group. Am J Clin Pathol 94:476-484
22. Libby P, Simon DI (2001) Inflammation and thrombosis: The clot thickens. Circulation 103:1718-1720
23. Kranzhofer R, Clinton SK, Ishii K, et al. (1996) Thrombin potently stimulates cytokine production in human vascular smooth muscle cells but not in mononuclear phagocytes. Circ Res 79:286-294
24. Schillinger M, Exner M, Mlekusch W, et al. (2002) Balloon angioplasty and stent implantation induce a vascular inflammatory reaction. J Endovasc Ther 9:59-66
25. Jialal I, Devaraj S (2003) Role of C-reactive protein in the assessment of cardiovascular risk. Am J Cardiol 91:200-202
26. Laws PE, Spark JI, Cowled PA, et al. (2004) The role of statins in vascular disease. Eur J Vasc Endovasc Surg 27:6-16
27. Laufs U, Gertz K, Huang P, et al. (2000) Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice. Stroke 31:2442-2449
28. Colli S, Eligini S, Lalli M, et al. (1997) Vastatins inhibit tissue factor in cultured human macrophages: A novel mechanism of protection against atherothrombosis. Arterioscler Thromb Vasc Biol 17:265-272
29. Jialal I, Devaraj S, Venugopal SK (2004) C-reactive protein: Risk marker or mediator in atherothrombosis? Hypertension 44:6-11
30. Inoue T, Sohma R, Miyazaki T, et al. (2000) Comparison of activation process of platelets and neutrophils after coronary stent implantation versus balloon angioplasty for stable angina pectoris. Am J Cardiol 86:1057-1062
31. Welt FG, Rogers C (2002) Inflammation and restenosis in the stent era.. Arterioscler Thromb Vasc Biol 22:1769-1776
32. Welt FG, Edelman ER, Simon DI, et al. (2000) Neutrophil, not macrophage, infiltration precedes neointimal thickening in balloon-injured arteries. Arterioscler Thromb Vasc Biol 20:2553-2558
33. Tanaka H, Sukhova GK, Swanson SJ, et al. (1993) Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury. Circulation 88:1788-1803
34. Miller DD, Karim MA, Edwards WD, et al. Relationship of vascular thrombosis and inflammatory leukocyte infiltration to neointimal growth following porcine coronary artery stent placement. Atherosclerosis 124:145-155
35. Welt FG, Tso C, Edelman ER, et al. (2003) Leukocyte recruitment and expression of chemokines following different forms of vascular injury. Vasc Med 8:1-7